Lexington Biosciences Inc. (LXGTF)

[Door2Door]

The real story here is not about a penny ticker up or down a percent or two. The real big factor in the LXGTF equation is that the first test HeartSentry monitors have been received from the manufacturer and Diablo Labs has been retained to conduct the clinical trials needed before FDA clearance. After that it's to market and then this ticker should skyrocket up. When? Within months. Mid 2018 IMO.